文献速递新生儿儿童神经与发育行为儿童感染

严重新生儿疾病与婴儿期至青春期晚期全因及病因特异性死亡率的关联

Severe Neonatal Morbidity and All-Cause and Cause-Specific Mortality Through Infancy and Late Adolescence.
PubMed 文献 · JAMA Pediatr · 2025-01-01

SNM与28天后至最长21.2岁的全因死亡率显著相关(aHR 5.92,95%CI 5.27-6.64),且神经系统疾病关联最强。

要点

  • SNM患儿28天后全因死亡风险显著升高(aHR 5.92,95%CI 5.27-6.64)。
  • 新生儿神经系统疾病与全因死亡率升高17.67倍相关(95%CI 15.08-20.71)。
  • SNM与感染、神经、循环、呼吸及代谢系统疾病死亡风险升高相关。

核心结论

  • 严重新生儿疾病可能是儿童期死亡的重要危险因素,预防SNM及早期识别和长期随访可能有助于进一步降低死亡率。

研究设计与样本

  • 暴露为出生后27天内任何SNM诊断或操作,主要结局为28天至最长21.2岁的全因和病因特异性死亡率,采用Cox比例风险模型估计aHR并调整婴儿和母亲特征,另进行同胞对照分析。

主要发现

  • SNM患儿死亡率为1.81/1000人年,无SNM者为0.13/1000人年,aHR为5.92(95%CI 5.27-6.64)。
  • 新生儿神经系统疾病是最主要的疾病类别,与28天后全因死亡率升高17.67倍相关(95%CI 15.08-20.71)。
  • SNM与全因死亡率的关联在女性儿童和足月儿中更高。
  • SNM与感染及神经、循环、呼吸和代谢系统疾病导致的死亡风险升高相关,持续至最早死亡日期、因移民删失或随访结束。

临床怎么用

  • 对SNM患儿应加强长期随访,关注感染、神经、循环、呼吸及代谢系统相关死亡风险。
  • 预防SNM并早期识别高危儿可能有助于降低儿童期死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Severe neonatal morbidity (SNM) has been associated with neonatal and early life mortality, yet its longer-term associations and cause-specific mortality remain unknown. OBJECTIVES: To examine the association between SNM during the first 27 postnatal days and all-cause and cause-specific mortality from infancy through late adolescence. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study was conducted in Sweden and involved 2 098 752 live-born singleton neonates with 22 or more weeks' gestation, born between January 2002 and December 2021, who survived and did not emigrate during the neonatal period. Mortality data were collected through March 2023, and data analysis was performed from July 2024 to December 2024. EXPOSURES: Neonates with any SNM diagnoses or procedures within 27 days after birth. MAIN OUTCOMES AND MEASURES: The primary outcomes were all-cause mortality and cause-specific mortality from 28 days up to a maximum of 21.2 years. Adjusted hazard ratios (aHRs) and 95% confidence intervals were estimated using Cox proportional hazards models and adjusted for infant and maternal characteristics. A sibling-control analysis was also performed. RESULTS: Among 2 098 752 children included in the study, 49 225 children (2.4%) were diagnosed with SNM during the neonatal period. During the median (IQR) follow-up duration of 10.5 (5.7-15.6) years, overall 3618 children died. The mortality rate for children with SNM was 1.81 per 1000 person-years compared with a rate of 0.13 per 1000 person-years for those without SNM, with an aHR of 5.92 (95% CI, 5.27-6.64). Neonatal neurological conditions were the leading morbidity, associated with a 17.67-fold increase in all-cause mortality after 28 days of life (95% CI, 15.08-20.71). The aHRs for the association between SNM and all-cause mortality were higher in female children than in male children and in those born at term. SNM was associated with elevated mortality risk from infections and disorders in the nervous, circulatory, respiratory, and metabolic systems until the earliest date of death, censoring due to emigration, or the end of follow-up. Sibling-control analysis showed the associations were unaffected by familial confounding. CONCLUSIONS AND RELEVANCE: Findings from this cohort study suggest that SNM may be a significant risk factor for childhood mortality. Efforts to prevent SNM, as well as early identification and long-term follow-up care, may help further reduce mortality.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Graham H, Johansson K, Persson M, et al. Severe Neonatal Morbidity and All-Cause and Cause-Specific Mortality Through Infancy and Late Adolescence. JAMA Pediatr. 2025. PMID: 40493844. doi:10.1001/jamapediatrics.2025.1873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。